Evidence of drug-response heterogeneity rapidly generated from a single cancer cell

被引:9
|
作者
Wang, Rong [1 ]
Jin, Chengmeng [1 ]
Hu, Xun [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Canc Inst,Sch Med, Minist Educ Peoples Republ China,Key Lab Canc Pre, Hangzhou, Zhejiang, Peoples R China
关键词
heterogeneity; cancer; drug-response; STOCHASTIC GENE-EXPRESSION; INTRATUMOR HETEROGENEITY; INDUCED APOPTOSIS; LACTIC-ACIDOSIS; RESISTANCE; EVOLUTION; VARIABILITY; GLYCOLYSIS; ISSUE; LUNG;
D O I
10.18632/oncotarget.17064
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One cancer cell line is believed to be composed of numerous clones with different drug sensitivity. We sought to investigate the difference of drug-response pattern in clones from a cell line or from a single cell. We showed that 22 clones derived from 4T1 cells were drastically different from each other with respect to drug-response pattern against 11 anticancer drugs and expression profile of 19 genes associated with drug resistance or sensitivity. Similar results were obtained using daughter clones derived from a single 4T1 cell. Each daughter clone showed distinct drug-response pattern and gene expression profile. Similar results were also obtained using Bcap37 cells. We conclude that a single cancer cell can rapidly produce a population of cells with high heterogeneity of drug response and the acquisition of drug-response heterogeneity is random.
引用
收藏
页码:41113 / 41124
页数:12
相关论文
共 50 条
  • [21] Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer
    Vidhi Malik
    Yogesh Kalakoti
    Durai Sundar
    BMC Genomics, 22
  • [22] A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer
    Luo, Kangjia
    Song, Yanni
    Guan, Zilong
    Ou, Suwen
    Ye, Jinhua
    Ran, Songlin
    Wang, Hufei
    Tao, Yangbao
    Gong, Zijian
    Ma, Tianyi
    Jin, Yinghu
    Huang, Rui
    Gao, Feng
    Yu, Shan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
    Stefanie Bärthel
    Chiara Falcomatà
    Roland Rad
    Fabian J. Theis
    Dieter Saur
    Nature Cancer, 2023, 4 : 454 - 467
  • [24] Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer
    Malik, Vidhi
    Kalakoti, Yogesh
    Sundar, Durai
    BMC GENOMICS, 2021, 22 (01)
  • [25] DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity
    Anchang, Benedict
    Davis, Kara L.
    Fienberg, Harris G.
    Williamson, Brian D.
    Bendall, Sean C.
    Karacosta, Loukia G.
    Tibshirani, Robert
    Nolan, Garry P.
    Plevritis, Sylvia K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (18) : E4294 - E4303
  • [26] A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
    Senkowski, Wojciech
    Gall-Mas, Laura
    Falco, Matias Marin
    Li, Yilin
    Lavikka, Kari
    Kriegbaum, Mette C.
    Oikkonen, Jaana
    Bulanova, Daria
    Pietras, Elin J.
    Vossgrone, Karolin
    Chen, Yan-Jun
    Erkan, Erdogan Pekcan
    Dai, Jun
    Lundgren, Anastasia
    Hog, Mia Kristine Gronning
    Larsen, Ida Marie
    Lamminen, Tarja
    Kaipio, Katja
    Huvila, Jutta
    Virtanen, Anni
    Engelholm, Lars
    Christiansen, Pernille
    Santoni-Rugiu, Eric
    Huhtinen, Kaisa
    Carpen, Olli
    Hynninen, Johanna
    Hautaniemi, Sampsa
    Vaharautio, Anna
    Wennerberg, Krister
    DEVELOPMENTAL CELL, 2023, 58 (12) : 1106 - +
  • [27] Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines
    Wandishin, Clayton M.
    Robbins, Charles John
    Tyson, Darren R.
    Harris, Leonard A.
    Quaranta, Vito
    CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 358 - 368
  • [28] Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells
    Wang, Ziruoyu
    Li, Yanan
    Zhao, Wensi
    Jiang, Shuai
    Huang, Yuqi
    Hou, Jun
    Zhang, Xuelu
    Zhai, Zhaoyu
    Yang, Chen
    Wang, Jiaqi
    Zhu, Jiying
    Pan, Jianbo
    Jiang, Wei
    Li, Zengxia
    Ye, Mingliang
    Tan, Minjia
    Jiang, Haowen
    Dang, Yongjun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [29] Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro
    Melanie Arul
    April Camilla Roslani
    Swee Hung Cheah
    In Vitro Cellular & Developmental Biology - Animal, 2017, 53 : 435 - 447
  • [30] Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro
    Arul, Melanie
    Roslani, April Camilla
    Cheah, Swee Hung
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2017, 53 (05) : 435 - 447